RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Raja, FA
  • Perren, TJ
  • Embleton, A
  • Rustin, GJS
  • Jayson, G
  • Swart, AM
  • Vaughan, M
  • Hirte, Holger
  • Stark, DP
  • Ledermann, JA

publication date

  • October 1, 2013